Drugs / Danhong injection
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02007187 | Dec 2013 → Aug 2017 | intermediate coronary syndrome | China Academy of Chinese Medical Sciences | Completed | Missed primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Danhong injection | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02007187 ↗ |
| Known as | DHI | “Danhong injection (DHI)，which is extracted from Salviae miltiorrhizae and Flos carthami，has been widely prescribed to patients with unstable angina pectoris (UAP) in China.” PMID 34732357 ↗ Oct 2021 |
| Modality | Traditional medicine (herbal / TCM) | “A kind of injection made from two kind of Chinese herbs: salvia miltiorrhiza and safflower” NCT02007187 ↗ |
| Route | Intravenous | “given by continuous IV infusion at 2.5ml/min within 2-3 hours every day for 7 days.” NCT02007187 ↗ |